highperformr logo

Amprion's Overview

Total employees36
HeadquartersSan Diego
Founded2007

Amprion is a pioneering biotechnology company dedicated to transforming the diagnosis of neurodegenerative diseases. They specialize in the detection of misfolded proteins, such as alpha-synuclein and tau, which are key biomarkers for conditions like Parkinson's Disease, Lewy Body Dementia, and Alzheimer's Disease. Amprion's cutting-edge SYNTap® Biomarker Test, utilizing their proprietary Seed Amplification Assay (SAA) technology, offers a highly sensitive and specific method for early detection, aiding in more accurate diagnoses, patient stratification for clinical trials, and the development of new therapies. The company is committed to improving patient outcomes by providing clinicians with critical diagnostic tools.

Where is Amprion's Headquarters?

Amprion officeAmprion officeAmprion officeAmprion office
*Images sourced via web search. Rights belong to original owners

HQ Function

The San Diego headquarters serves as Amprion's primary center for research and development, CLIA-certified laboratory operations, corporate administration, strategic planning, and commercialization efforts.

Notable Features:

Features state-of-the-art laboratory facilities, including a CLIA-certified and CAP-accredited lab, specifically designed for ultrasensitive protein misfolding detection assays. Its location within a prominent San Diego biotech park provides access to a rich ecosystem of talent and collaboration.

Work Culture:

Amprion fosters an innovative, science-driven, and collaborative work culture. Employees are mission-focused on tackling complex neurodegenerative diseases, with a strong emphasis on scientific rigor, precision, quality, and making a tangible impact on patient lives.

HQ Significance:

The headquarters' location in San Diego is highly significant, offering unparalleled access to a skilled biotech workforce, leading academic research institutions, potential industry partners, and venture capital, all crucial for Amprion's growth and innovation in the diagnostics field.

Values Reflected in HQ: The headquarters reflects Amprion's core values of scientific excellence, innovation in diagnostics, commitment to quality assurance (evidenced by CLIA certification and CAP accreditation), and a patient-centric approach to addressing unmet medical needs in neurodegenerative disorders.

Location:

While Amprion's primary operations and laboratories are based in the United States, the company supports global initiatives through research collaborations, participation in international scientific conferences, and aims for future worldwide distribution of its diagnostic tests. Their technology is utilized in clinical studies that may involve international sites, contributing to a global understanding and approach to neurodegenerative diseases.

Street Address:

10030 Barnes Canyon Rd, Suite 100

City:

San Diego

State/Province:

CA

Country:

USA

Amprion's Global Presence

Buying Intent Signals for Amprion

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Amprion

As of April 2025, Amprion' leadership includes:

Russell Lebovitz, MD, PhD - Chief Executive Officer & Co-Founder
Claudio Soto, PhD - Chief Scientific Officer & Co-Founder
Kendyle Woodard - Chief Operating Officer
Hanns-Peter Scharf, PhD - Vice President, Technology
Nicole K. Severson, PhD - Head of Operations

Investors of Amprion

Amprion has been backed by several prominent investors over the years, including:

Vensana Capital
Omega Funds
Alzheimer's Drug Discovery Foundation (ADDF)
Dolby Family Ventures
Baxter Ventures
National Institutes of Health (NIH)

Executive New Hires/Exits in the Last 12 Months

Hire0
Exits0

No major C-suite executive hires or departures have been widely publicized for Amprion in the immediate past 12 months (approx. mid-2023 to mid-2024). The leadership team appears stable, with key personnel continuing in their established roles.

Technology (Tech Stack) used by Amprion

Discover the tools Amprion uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Amprion Email Formats and Examples

Amprion commonly utilizes the email format consisting of the employee's first initial followed by their last name, preceding the '@ampriondx.com' domain. For example, an employee named Jane Doe would likely have an email address like 'jdoe@ampriondx.com'.

[first_initial][last]@ampriondx.com

Format

rlebovitz@ampriondx.com

Example

85%

Success rate

News and media

Amprion WebsiteMay 1, 2024

Amprion to Present Data on SYNTap® Synuclein Test at the International Congress of Parkinson’s Disease and Movement Disorders®

Amprion announced its participation and presentation of new data on its SYNTap® alpha-synuclein seed amplification assay at the upcoming International Congress of Parkinson’s Disease and Movement Disorders®. The presentations will highlight the test's utility in detecting synucleinopathy, even in its early stages....more

PR NewswireJuly 28, 2023

Amprion Announces Positive Topline Results from its Pivotal Clinical Validation Study for SYNTap® Biomarker Test as an Aid in Diagnosing Parkinson's Disease

Amprion reported positive topline results from a pivotal clinical validation study of its SYNTap® test. The study demonstrated high accuracy in differentiating Parkinson's disease patients from healthy controls, underscoring its potential as a diagnostic aid....more

Business WireApril 17, 2023

Amprion Awarded FDA Breakthrough Device Designation for SYNTap® Biomarker Test as an Aid in Diagnosing Parkinson’s Disease

Amprion received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its SYNTap® Biomarker Test. This designation is intended to expedite the development and review of medical devices that offer more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Amprion, are just a search away.